Ideally:Quarterly for July1 -Sep30 sometime this week which...

Ideally:
Quarterly for July1 -Sep30 sometime this week which should put evidence to the "our sales of raw product are increasing" claims made, then AGM, then clinical trial results, then forward to manufacturing with a partner in Q3FY2020 and revenues take us from $200k in sales to something that means we aren't solely dependant on R&D rebates for cash. Then the company is a very different beast, and the market roulette wheel gets another spin.

Risks:
ADO has almost manufactured a product several times before though. One time they even owned their own factory.
AGM paperwork has a set of motions in it that may or may not pass, their outcome affects the Company as much as any sales figures or share pricing trend.
Product going into competitive market and competing directly with one of our raw-materials customers, sales depend on market penetration, etc.

Future predictions:
10.5c isn't hard to achieve even today, just organise someone to buy 10mil shares during their lunch hour - keeping it there needs more confidence or facts being fed into the market, though.
COVID crisis will eventually end, alternative product lines must be online by the time a vaccine arrives as that will tank the COVID-test profitability, revenues need be stable by then, etc.
Eventually, heat-death of the universe occurs.

But if you want anybody to tell you more parts of an uncertain future, give them a more certain time period to make predictions against.